People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.
AstraZeneca said on Monday its ‌experimental treatment tozorakimab showed a "meaningful reduction" in moderate-to-severe ...
Select your location to view local American Lung Association events and news near you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results